Antibody Engineering & Therapeutics is going virtual this year, but is still the #1 conference for accelerating next generation antibodies to commercial success.
SCT sponsored a scientific briefing and offered a poster presentation. Dr. Chun-Nan Chen shared a talk with advances to SCT's AbTheneum™ technology, including case studies.
For more information about Antibody Engineering & Therapeutics, click here.